Referred Tests
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing. | |
Test ID: MGMT
MGMT Promoter Methylation, Tumor
Useful For 
Suggests clinical disorders or settings where the test may be helpful
Prognostication of newly diagnosed glioblastomas
Identifying newly diagnosed glioblastomas that may respond to alkylating chemotherapy (ie, temozolomide)
Guiding therapy decision making for newly diagnosed glioblastomas in elderly patients (>60 years)
Highlights
MGMT promoter methylation status has prognostic and predictive value for glioblastoma patients
Additional Tests Lists tests that are always performed, at an additional charge, with the initial tests.
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| SLIRV | Slide Review in MG | No, (Bill Only) | Yes |
Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
When this test is ordered, slide review will always be performed at an additional charge.
Method Name A short description of the method used to perform the test
Methylation-Specific Polymerase Chain Reaction (PCR) Analysis
NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Reporting Name Lists a shorter or abbreviated version of the Published Name for a test
MGMT Promoter Methylation, Tumor